Back

Semaglutide and dapagliflozin synergistically prevent cancer therapy-related cardiac dysfunction in hyperglycemic conditions

3 April 2025 (08:00 - 19:00)
Organised by: Logo
Congress Presentation Part of: Cardiovascular protection in patients with cancer Cardio-Oncology EAPC Premium Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Vincenzo Quagliariello

National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)

2 More presentations in this session

Presentation thumbnail
PSA - a potential biomarker for the intersection of screening for cardiovascular disease and cancer
Ms E. Unger (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Cardioprotective effects of prophylactic ACE Inhibitors in anthracycline-based chemotherapy: a systematic review and meta-analysis
Mr D. Pizzi (Milano, IT)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular protection in patients with cancer

The Event

Event poster

ESC Preventive Cardiology 2025

3 April - 5 April 2025

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources